Datadog, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Datadog, Inc. stock analysis DDOG overview
Bullish +75

Stock Movers: Intel, Zoetis, Datadog

📈 Intel stock rallied after reports of a preliminary agreement with Apple to manufacture chips for its devices.

💻 Bloomberg noted Apple held discussions to use Intel and Samsung as secondary processor options beyond TSMC in the US.

🐶 Zoetis shares plummeted 22% to $87.31 after missing first-quarter sales expectations due to reduced US pet spending.

💊 The animal health giant cut its 2026 earnings forecast by 10 cents, guiding for full-year earnings of up to $7 per share.

📉 Drug sales for US pets declined 11% in the quarter, partly attributed to rising inflation costs for consumers.

☁️ Datadog stock surged 31% to close at $188.73, marking its highest settlement price since September 2019.

💰 The software developer raised its full-year revenue outlook to between $4.3 billion and $4.34 billion.

📊 Wall Street expected Datadog's revenue to be approximately $4.09 billion, meaning the company significantly beat consensus estimates.

🏆 Datadog also adjusted its earnings guidance upward to a high of $2.44 per share from a previous top range of $2.16.

📈 Datadog represents one of the biggest gainers among this week's major stock movers, outperforming both Intel and Zoetis.

🎧 Bloomberg journalists analyzed these movements in their latest episode of the Stock Movers podcast series.

🌍 The broader market context includes discussions on geopolitical factors affecting semiconductor supply chains like Apple's strategy.

📅 These financial updates reflect significant shifts in investor sentiment toward technology and healthcare sectors this week.

Full Analysis
On the latest episode of Stock Movers, Bloomberg journalists analyzed top market gainers and losers, with Datadog (DDOG) emerging as a primary winner after surging 31% to close at $188.73 on Thursday, its highest settlement price since September 2019. This significant rally followed the company's earnings report where it raised its full-year sales outlook to a range of $4.3 billion to $4.34 billion, surpassing Wall Street's average estimate of $4.09 billion. Additionally, Datadog increased its adjusted earnings guidance to as much as $2.44 per share, up from the previous top-end forecast of $2.16 per share. The article also contextualizes this performance within the broader market movements that week. It contrasts DDOG's success with Intel (INTC), which rallied after news of a preliminary agreement with Apple to manufacture some chips for its devices, and Zoetis (ZTS), whose shares plummeted 22% after missing first-quarter sales expectations due to a decline in US pet drug sales and a lowered 2026 forecast. While the content mentions Intel and Zoetis as part of a weekly market overview, Datadog's specific financial results and guidance upgrades are detailed as the central reason for its six-year high stock price performance.